Please note: The information displayed on this page might be outdated.
VantAI: Provider of solutions intended for challenging the boundary of in-silico. The company's core offerings include drug repurposing, in-silico toxicology and adverse event prediction, enabling to uncover organ-specific side effect concerns with unprecedented biological explainability down to the pathway and protein level.
US - Middle Atlantic
New York, NY 10003
Company Participants at 2nd Solebury Trout Virtual Global Healthcare Conference Series
Dr. Zachary Carpenter serves as President at VantAI.
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.